Due to the involvement of IL-17 in carcinogenesis and its role in tumor resistance to treatment, many existing drugs that are known for their application in autoimmune diseases therapy could have a potential role in general oncological chemotherapy. This evidence concerns the gene IL17A and neoplasm.